Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
1 event,
Virtual Event
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […] |
1 event, |
2 events,
Virtual Event
Virtual Event
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […] |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
2 events,
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom. This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and […] |
1 event, |
1 event, |
|
1 event, |
1 event, |
1 event, |
1 event, |
2 events,
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […] |
1 event, |
|
1 event, |
1 event, |
1 event, |
1 event, |
3 events,
The European School of Oncology's Refresher Course on Sarcoma is an advanced educational event taking place from 25 to 27 September 2026 in Rome, Italy. Organized in collaboration with the Università Campus Bio-Medico di Roma, the program is led by Course Chair Sylvie Bonvalot (FR), Host Chair Bruno Vincenzi (IT), and College Representative Silvia Brotea-Mosoiu […] 
Hybrid Event
The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. Awarding 60 ECTS credits upon completion, the programme combines 10 online modules, two in-person seminars, […] |
||
3 events,
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 in Lugano, Switzerland. The course will focus on managing cancer-related symptoms, cachexia, nutritional needs, treatment toxicities, palliative care, end-of-life preparation, and communication with patients and […] |
4 events,
Virtual Event
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […] |
4 events,
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […] 
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […] |
